I think this ACS article describes the situation very well: http://cen.acs.org/articles/95/i9/Pushback.html http://cen.acs.org/articles/95/i9/Pushback.html It

I think this ACS article describes the situation very well: http://cen.acs.org/articles/95/i9/Pushback.html http://cen.acs.org/articles/95/i9/Pushback.html It's long but a very thorough treatment of the problem. The existing pharma system is very, very profitable and there is a ton of resistance to anything to rock that boat. Lately profitability has been coming from price increases instead of innovation but pharma is okay with that as long as it lets them pay billions in dividends.